Home » Healthcare » Pharmaceuticals » Pharmaceutical Contract Packaging Market

Pharmaceutical Contract Packaging Market By Packaging Type (Primary Packaging, Secondary Packaging, Tertiary Packaging); By Packaging Format (Blister Packaging, Bottles & Containers, Sachets & Pouches, Vials & Ampoules, Prefilled Syringes, Combination & Specialty Packaging); By Dosage Form (Solid Oral, Liquid, Semi-solid, Injectables, Biologics & Biosimilars); By End User (Innovator Pharma Companies, Generic Drug Manufacturers, Biopharma & CDMOs); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Name: Pharmaceutical Contract Packaging Market - Demand, Size and Competitive Analysis
Creator: Credence Research Inc.
Published: 2026-01-06
License: https://www.credenceresearch.com/info/privacy-policy
Keywords: Pharmaceutical Contract Packaging Market

Summary
Table Of Content
Request Free Sample

Market Overview:

The Global Pharmaceutical Contract Packaging Market size was valued at USD 23,220.90 million in 2018 to USD 32,946.20 million in 2024 and is anticipated to reach USD 52,165.40 million by 2032, at a CAGR of 5.92% during the forecast period.

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
Pharmaceutical Contract Packaging Market Size 2024	USD 32,946.20 million
Pharmaceutical Contract Packaging Market, CAGR	5.92%
Pharmaceutical Contract Packaging Market Size 2032	USD 52,165.40 million

The market grows due to rising outsourcing by pharmaceutical manufacturers. Drug companies focus more on core research activities. Packaging partners offer speed, scale, and regulatory expertise. Complex dosage forms increase packaging needs. Demand for blister, vial, and syringe packaging continues to rise. Strict safety and labeling rules support professional packaging services. Biologics and specialty drugs need advanced handling solutions. Contract packagers invest in automation and compliance systems. These factors strengthen long-term demand across branded and generic drugs.

North America leads due to strong pharmaceutical production and strict compliance standards. The United States shows high outsourcing adoption among large drug makers. Europe follows with strong presence of contract packaging specialists. Countries like Germany and the United Kingdom drive regional demand. Asia Pacific emerges as a fast-growing region. India and China expand due to cost advantages and manufacturing scale. Latin America and the Middle East show gradual growth. Expanding healthcare access supports future regional demand.

Market Insights:

The market was valued at USD 23,220.90 million in 2018, reached USD 32,946.20 million in 2024, and is projected to hit USD 52,165.40 million by 2032, growing at a CAGR of 5.92%.
Asia Pacific led with about 33% share, followed by Europe at nearly 27% and North America at around 24%, driven by strong pharma manufacturing, outsourcing depth, and regulatory maturity.
Asia Pacific remains the fastest-growing region with roughly 33% share, supported by cost advantages, high generic drug output, and expanding export-focused production.
By packaging type, secondary packaging accounted for about 42% share, while primary packaging held close to 38%, reflecting strong demand for compliance, labeling, and product protection.
Tertiary packaging contributed nearly 20% share, supported by rising bulk distribution, logistics efficiency needs, and global pharmaceutical trade growth.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

Market Drivers:

Rising Outsourcing Demand From Pharmaceutical Manufacturers

The Global Pharmaceutical Contract Packaging Market benefits from higher outsourcing across drug manufacturers. Companies aim to reduce fixed operational costs. External partners provide flexible capacity during demand shifts. It supports faster product launches across markets. Regulatory complexity pushes firms toward specialized packaging providers. These providers ensure compliance with global quality standards. Growing generic drug volumes increase packaging workloads. Contract partners help manage peak production cycles efficiently.

For instance, Catalent operates 50+ global facilities and runs hundreds of packaging lines for oral and injectable products. Contract partners manage peak cycles efficiently. Compliance support strengthens outsourcing decisions.

Increasing Complexity Of Drug Delivery Formats And Packaging Needs

Advanced drug delivery formats raise packaging requirements. Injectables, biologics, and combination products need precision handling. It supports demand for sterile and controlled packaging services. Unit-dose and patient-centric formats gain priority. Packaging accuracy protects product stability and safety. Pharmaceutical firms prefer partners with validated processes. This driver supports steady service adoption. Technical expertise strengthens long-term outsourcing decisions.

For instance, Lonza supports biologics with validated aseptic filling lines across multiple sites. Unit-dose formats improve patient safety. Pharmaceutical firms prefer partners with proven validation records. Technical expertise drives long-term contracts.

Stringent Regulatory And Safety Compliance Requirements

Regulatory authorities enforce strict packaging standards worldwide. Serialization and traceability rules raise compliance costs. It benefits firms with proven regulatory systems. Drug safety concerns increase scrutiny on labeling accuracy. Tamper-evident packaging becomes a standard requirement. Contract packagers invest in audit-ready facilities. Pharmaceutical companies reduce compliance risk through outsourcing. This factor drives sustained market reliance.

Growth In Global Pharmaceutical Production And Distribution Networks

Pharmaceutical production expands across multiple regions. Cross-border drug distribution raises packaging complexity. It supports demand for standardized global packaging solutions. Contract packagers manage multilingual labeling needs. They support rapid scaling across geographies. Pharmaceutical exports depend on compliant packaging formats. Supply chain efficiency improves through specialized partners. This growth supports long-term service demand.

Market Trends:

Adoption Of Serialization And Track And Trace Technologies

The Global Pharmaceutical Contract Packaging Market shows strong adoption of serialization systems. Governments mandate product traceability across supply chains. It drives investment in digital packaging infrastructure. Contract packagers deploy integrated coding systems. Data capture improves recall response capabilities. Pharmaceutical firms value real-time tracking support. This trend improves transparency across distribution networks. Technology adoption enhances partner selection criteria.

For instance, Sharp Packaging Services confirms full compliance with EU Falsified Medicines Directive requirements, supporting end-to-end serialization across large-scale prescription packaging lines.

Shift Toward Patient-Centric And Unit-Dose Packaging Formats

Patient-centric packaging gains strong attention across markets. Unit-dose packs improve adherence and dosing accuracy. It supports blister and sachet packaging demand. Elderly and chronic patients prefer easy-use formats. Pharmaceutical brands enhance user experience through packaging design. Contract packagers offer customization capabilities. This trend supports premium service differentiation. Packaging design becomes a competitive factor.

For instance, Catalent expanded its unit-dose blister packaging operations to support adherence-focused therapies for chronic disease management.

Increased Automation And Digital Integration In Packaging Operations

Automation expands across contract packaging facilities. Robotics improve speed and consistency in operations. It reduces error rates and manual handling risks. Digital systems support batch tracking and reporting. Pharmaceutical clients demand high process visibility. Automated inspection systems ensure quality assurance. This trend improves operational efficiency. Investment in smart packaging lines continues.

Growing Focus On Sustainable And Eco-Friendly Packaging Materials

Sustainability gains importance in pharmaceutical packaging strategies. Clients prefer reduced plastic and recyclable materials. It supports innovation in material selection. Contract packagers align with corporate sustainability goals. Lightweight packaging reduces logistics impact. Regulatory pressure supports eco-friendly practices. This trend reshapes supplier qualification standards. Environmental compliance influences long-term contracts.

Market Challenges Analysis:

Regulatory Variability And Compliance Management Across Regions

The Global Pharmaceutical Contract Packaging Market faces complex regulatory variation. Each region applies different packaging rules. It increases compliance management costs. Frequent regulatory updates require process adjustments. Smaller providers face resource limitations. Audit readiness demands constant documentation control. Pharmaceutical clients expect zero compliance gaps. This challenge affects operational scalability.

Cost Pressures And Capacity Constraints During Demand Surges

Contract packagers face rising operational costs. Labor, energy, and compliance expenses increase steadily. It pressures profit margins across services. Sudden demand surges strain available capacity. Facility expansion requires high capital investment. Skilled workforce shortages limit output growth. Clients demand short turnaround times. These factors challenge service consistency.

Market Opportunities:

Expansion Of Biologics, Specialty Drugs, And Clinical Trial Packaging

The Global Pharmaceutical Contract Packaging Market gains opportunity from biologics growth. Specialty drugs require advanced packaging expertise. It supports demand for sterile and cold-chain services. Clinical trial volumes increase across regions. Small batch packaging needs specialized handling. Contract packagers offer flexible production models. Pharmaceutical innovators prefer experienced partners. This segment supports high-value service growth.

Rising Pharmaceutical Manufacturing In Emerging Economies

Emerging markets expand pharmaceutical manufacturing capacity. India, China, and Southeast Asia show strong momentum. It creates demand for local contract packaging services. Export-oriented production increases compliance needs. Global firms seek regional packaging partners. Infrastructure investment improves service quality. Market entry barriers reduce gradually. This opportunity supports geographic expansion.

Market Segmentation Analysis:

Packaging Type

Primary packaging holds a critical role due to direct drug contact and safety needs. It supports integrity, stability, and contamination control. Secondary packaging strengthens protection, branding, and regulatory labeling. It enables efficient handling across supply chains. Tertiary packaging supports bulk movement and logistics efficiency. It improves storage safety during large-scale distribution. Demand across all three types remains steady due to compliance and scale needs.

For instance, Amcor supplies pharmaceutical blister films with certified moisture and oxygen barrier performance for regulated drug packaging.

Packaging Format

Blister packaging leads due to dose accuracy and patient convenience. Bottles and containers support high-volume solid and liquid drugs. Sachets and pouches gain use in unit-dose and trial packs. Vials and ampoules serve injectables with strict sterility needs. Prefilled syringes grow with self-administration trends. Combination and specialty packaging supports complex therapies. Format choice depends on drug type and distribution channel.

For instance, West Pharmaceutical Services manufactures billions of elastomer closures annually, supporting sterile injectable packaging for global pharmaceutical producers.

Dosage Form

Solid oral dosage dominates due to high prescription volumes. Liquid forms require precise sealing and leakage control. Semi-solid packaging supports topical and dermatology drugs. Injectables demand aseptic and validated packaging lines. Biologics and biosimilars require cold-chain compatible solutions. It drives demand for advanced handling expertise. Dosage diversity expands service scope for contract packagers.

End User

Innovator pharma companies outsource to speed launches and manage compliance. Generic drug manufacturers seek cost efficiency and scale support. Biopharma and CDMOs rely on specialized packaging partners. It supports clinical, commercial, and lifecycle needs. The Global Pharmaceutical Contract Packaging Market benefits from demand across all end users. Each group values reliability, flexibility, and regulatory strength.

Segmentation:

By Packaging Type

Primary Packaging
Secondary Packaging
Tertiary Packaging

By Packaging Format

Blister Packaging
Bottles & Containers
Sachets & Pouches
Vials & Ampoules
Prefilled Syringes
Combination & Specialty Packaging

By Dosage Form

Solid Oral
Liquid
Semi-solid
Injectables
Biologics & Biosimilars

By End User

Innovator Pharma Companies
Generic Drug Manufacturers
Biopharma & CDMOs

By Region:

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

Regional Analysis:

North America

The North America Global Pharmaceutical Contract Packaging Market size was valued at USD 5,598.55 million in 2018 to USD 7,841.67 million in 2024 and is anticipated to reach USD 12,201.50 million by 2032, at a CAGR of 5.69% during the forecast period. North America held nearly 24% market share in 2024. The region benefits from advanced pharmaceutical manufacturing capacity. The United States leads due to strong outsourcing adoption. Strict regulatory frameworks increase reliance on compliant packaging partners. High biologics production supports demand for sterile packaging. Contract packagers invest in automation and traceability. Mature healthcare infrastructure supports steady service demand. Strong R&D activity sustains long-term growth.

Europe

The Europe Global Pharmaceutical Contract Packaging Market size was valued at USD 6,269.63 million in 2018 to USD 8,768.40 million in 2024 and is anticipated to reach USD 13,615.18 million by 2032, at a CAGR of 5.67% during the forecast period. Europe accounted for about 27% market share in 2024. Germany, France, and the UK lead regional demand. Strong regulatory oversight drives outsourcing preference. The region shows high adoption of serialization standards. Contract packagers support cross-border drug distribution. Biopharma activity supports specialty packaging demand. Sustainability initiatives influence material choices. Stable pharmaceutical exports support market continuity.

Asia Pacific

The Asia Pacific Global Pharmaceutical Contract Packaging Market size was valued at USD 7,586.26 million in 2018 to USD 10,858.13 million in 2024 and is anticipated to reach USD 17,391.96 million by 2032, at a CAGR of 6.08% during the forecast period. Asia Pacific held nearly 33% market share in 2024. China and India drive regional expansion. Cost advantages support outsourcing growth. Expanding generic drug production boosts packaging volumes. Regional governments invest in healthcare manufacturing. Contract packagers scale capacity rapidly. Export-focused production raises compliance needs. The region shows strong long-term momentum.

Latin America

The Latin America Global Pharmaceutical Contract Packaging Market size was valued at USD 2,034.15 million in 2018 to USD 2,990.58 million in 2024 and is anticipated to reach USD 4,955.72 million by 2032, at a CAGR of 6.53% during the forecast period. Latin America represented around 9% market share in 2024. Brazil and Mexico lead regional demand. Growing local drug manufacturing supports outsourcing. Regulatory alignment improves service adoption. Multinational firms expand regional operations. Contract packagers strengthen compliance capabilities. Healthcare access expansion supports packaging needs. The region shows rising investment interest.

Middle East

The Middle East Global Pharmaceutical Contract Packaging Market size was valued at USD 1,109.96 million in 2018 to USD 1,638.37 million in 2024 and is anticipated to reach USD 2,728.25 million by 2032, at a CAGR of 6.59% during the forecast period. The region held about 5% market share in 2024. GCC countries drive pharmaceutical investments. Local production reduces import dependence. Governments support healthcare localization programs. Contract packaging demand grows steadily. Compliance standards continue to improve. Regional hubs attract multinational partnerships. Growth remains structurally positive.

Africa

The Africa Global Pharmaceutical Contract Packaging Market size was valued at USD 622.32 million in 2018 to USD 849.07 million in 2024 and is anticipated to reach USD 1,272.84 million by 2032, at a CAGR of 5.20% during the forecast period. Africa accounted for nearly 3% market share in 2024. South Africa leads regional activity. Healthcare infrastructure development supports demand. Local manufacturing initiatives gain traction. Contract packagers focus on basic compliance services. Import substitution policies drive packaging needs. International aid supports medicine access programs. The region shows gradual but stable growth.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis:

Catalent Pharma Solutions
Sharp Packaging Services
PCI Pharma Services
Thermo Fisher Scientific
Amcor
North East Pharma Pack
Aptar Group
West Pharmaceutical Services
Berry Global

Competitive Analysis:

The Global Pharmaceutical Contract Packaging Market shows moderate consolidation with global and regional players. Leading companies compete on compliance strength, capacity scale, and service breadth. It favors firms with validated sterile and high-speed packaging lines. Strategic focus remains on reliability and turnaround speed. Players invest in automation and digital traceability tools. Strong client retention depends on audit readiness and regulatory history. Global operators leverage multi-region footprints for large pharma clients. Mid-sized firms compete through niche capabilities and flexibility. Competitive intensity remains steady across major regions.

Recent Developments:

In October 2025, Sharp Packaging Services announced a comprehensive $100 million global investment program spanning its North American and European pharmaceutical packaging facility network. The investment demonstrates the company’s confidence in sustained demand growth for injectable and oral solid dose pharmaceutical packaging services. In the United States, the investment adds sterile fill-finish capacity at the Lee, Massachusetts location, while the Allentown, Pennsylvania campus will receive new state-of-the-art pre-filled syringe assembly and labeling lines, high-speed bottling equipment for oral solid dose products, and automated pouch filling systems. The Macungie, Pennsylvania facility is doubling in size through this investment program, with new production suites for assembly, labeling, and packaging of injectables, supported by ambient warehouse space and enhanced cold storage. The Bethlehem, Pennsylvania location, which offers clinical services from preclinical through commercial stages, is being outfitted with new cold-chain storage, capsule filling machines, and additional blister packaging lines for oral solid dose products, with these capabilities anticipated to be operational by the end of 2025. In Europe, Sharp’s Netherlands facility is enhancing GMP production capacity for vial labeling and injectables packaging, scheduled to come online in 2026, while Belgium is undertaking a significant warehouse expansion incorporating additional cold-chain and ambient storage alongside a new syringe blistering production suite. Additionally, Sharp established a preferred partnership with Berkshire Sterile Manufacturing (BSM) to augment its clinical manufacturing services, leveraging BSM’s proprietary 100% isolator-based sterile filling technology for syringes, vials, and cartridges. With nine GMP facilities globally and over 2,500 employees, Sharp positions itself as a comprehensive partner supporting pharmaceutical clients across the entire product lifecycle.
Thermo Fisher Scientific aggressively expanded its pharmaceutical services capabilities through strategic acquisitions in 2025. In July 2025, the company announced an agreement to acquire Sanofi’s state-of-the-art sterile manufacturing facility in Ridgefield, New Jersey, with expected completion targeted for the second half of 2025. The Ridgefield facility represents a strategically valuable asset featuring world-class sterile fill-finish and pharmaceutical packaging capabilities and employing over 200 specialized personnel who will transition to Thermo Fisher’s pharmaceutical services division. Under the expanded partnership arrangement, Thermo Fisher committed to continuing manufacturing of Sanofi’s therapeutic portfolio while simultaneously expanding facility capacity to serve the broader pharmaceutical and biotechnology customer base seeking U.S.-based manufacturing capacity. Complementing this acquisition, Thermo Fisher completed the acquisition of Solventum’s purification and filtration business in September 2025, further consolidating its laboratory and biopharma services infrastructure. These strategic acquisitions position Thermo Fisher as a comprehensive solutions provider capable of delivering integrated development, manufacturing, and analytical services to pharmaceutical customers.
Aptar Group has pursued an aggressive acquisition and partnership strategy throughout 2025 to expand its pharmaceutical services and digital health capabilities. In July 2025, Aptar Pharma announced the acquisition of Mod3 Pharma’s clinical trial materials manufacturing capabilities from SWK Holdings. This strategic acquisition significantly enhanced Aptar’s early-stage drug development services, providing formulation, fill-and-finish capabilities for Phase I and Phase II clinical trials with comprehensive cGMP compliance and an FDA-inspected facility in New Jersey. The acquisition built upon an existing partnership focused on cGMP fill-and-finish services for orally inhaled and nasal drug products (OINDPs), enabling Aptar to offer accelerated pathways for new drug delivery technologies across dermal, ophthalmic, injectable, and secondary packaging applications leveraging Aptar’s proprietary Active Material Science Solutions.

Report Coverage:

The research report offers an in-depth analysis based on Packaging Type and Packaging Format segments. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook:

Outsourcing adoption will rise among branded and generic drug manufacturers.
Demand for sterile and biologics packaging will expand steadily.
Automation will improve speed, accuracy, and compliance control.
Serialization requirements will shape service selection criteria.
Asia Pacific will attract new capacity investments.
Sustainability goals will influence packaging material choices.
Clinical trial packaging demand will remain strong.
Regional contract packagers will expand service depth.
Digital traceability will support supply chain transparency.
Long-term contracts will favor compliant and scalable providers.

CHAPTER NO. 1 : GENESIS OF THE MARKET

1.1 Market Prelude – Introduction & Scope

1.2 The Big Picture – Objectives & Vision

1.3 Strategic Edge – Unique Value Proposition

1.4 Stakeholder Compass – Key Beneficiaries

CHAPTER NO. 2 : EXECUTIVE LENS

2.1 Pulse of the Industry – Market Snapshot

2.2 Growth Arc – Revenue Projections (USD Million)

2.3. Premium Insights – Based on Primary Interviews

CHAPTER NO. 3 : PHARMACEUTICAL CONTRACT PACKAGING MARKET FORCES & INDUSTRY PULSE

3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown

CHAPTER NO. 4 : KEY INVESTMENT EPICENTER

4.1 Regional Goldmines – High-Growth Geographies

4.2 Product Frontiers – Lucrative Packaging Type Categories

4.3 Packaging Format Sweet Spots – Emerging Demand Segments

CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING

5.1 Momentum Metrics – Forecast & Growth Curves

5.2 Regional Revenue Footprint – Market Share Insights

5.3 Segmental Wealth Flow – Packaging Type, Packaging Format, Dosage Form, & End User Revenue

CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS

6.1. Import Analysis By Region

6.1.1. Global Pharmaceutical Contract Packaging Market Import Revenue By Region

6.2. Export Analysis By Region

6.2.1. Global Pharmaceutical Contract Packaging Market Export Revenue By Region

CHAPTER NO. 7 : COMPETITION ANALYSIS

7.1. Company Market Share Analysis

7.1.1. Global Pharmaceutical Contract Packaging Market: Company Market Share

7.2. Global Pharmaceutical Contract Packaging Market Company Revenue Market Share

7.3. Strategic Developments

7.3.1. Acquisitions & Mergers

7.3.2. New Services Launch

7.3.3. Regional Expansion

7.4. Competitive Dashboard

7.5. Company Assessment Metrics, 2024

CHAPTER NO. 8 : PHARMACEUTICAL CONTRACT PACKAGING MARKET – BY PACKAGING TYPE SEGMENT ANALYSIS

8.1. Pharmaceutical Contract Packaging Market Overview By Packaging Type Segment

8.1.1. Pharmaceutical Contract Packaging Market Revenue Share By Packaging Type

8.2. Primary Packaging

8.3. Secondary Packaging

8.4. Tertiary Packaging

CHAPTER NO. 9 : PHARMACEUTICAL CONTRACT PACKAGING MARKET – BY PACKAGING FORMAT SEGMENT ANALYSIS

9.1. Pharmaceutical Contract Packaging Market Overview By Packaging Format Segment

9.1.1. Pharmaceutical Contract Packaging Market Revenue Share By Packaging Format

9.2. Blister Packaging

9.3. Bottles & Containers

9.4. Sachets & Pouches

9.5. Vials & Ampoules

9.6. Prefilled Syringes

9.7. Combination & Specialty Packaging

CHAPTER NO. 10 : PHARMACEUTICAL CONTRACT PACKAGING MARKET – BY DOSAGE FORM SEGMENT ANALYSIS

10.1. Pharmaceutical Contract Packaging Market Overview By Dosage Form Segment

10.1.1. Pharmaceutical Contract Packaging Market Revenue Share By Dosage Form

10.2. Solid Oral

10.3. Liquid

10.4. Semi-solid

10.5. Injectables

10.6. Biologics & Biosimilars

CHAPTER NO. 11 : PHARMACEUTICAL CONTRACT PACKAGING MARKET – BY END USER SEGMENT ANALYSIS

11.1. Pharmaceutical Contract Packaging Market Overview By End User Segment

11.1.1. Pharmaceutical Contract Packaging Market Revenue Share By End User

11.2. Innovator Pharma Companies

11.3. Generic Drug Manufacturers

11.4. Biopharma & CDMOs

CHAPTER NO. 12 : PHARMACEUTICAL CONTRACT PACKAGING MARKET – REGIONAL ANALYSIS

12.1. Pharmaceutical Contract Packaging Market Overview By Region Segment

12.1.1. Global Pharmaceutical Contract Packaging Market Revenue Share By Region

12.1.2. Regions

12.1.3. Global Pharmaceutical Contract Packaging Market Revenue By Region

12.1.4. Packaging Type

12.1.5. Global Pharmaceutical Contract Packaging Market Revenue By Packaging Type

12.1.6. Packaging Format

12.1.7. Global Pharmaceutical Contract Packaging Market Revenue By Packaging Format

12.1.8. Dosage Form

12.1.9. Global Pharmaceutical Contract Packaging Market Revenue By Dosage Form

12.1.10. End User

12.1.11. Global Pharmaceutical Contract Packaging Market Revenue By End User

CHAPTER NO. 13 : NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET – COUNTRY ANALYSIS

13.1. North America Pharmaceutical Contract Packaging Market Overview By Country Segment

13.1.1. North America Pharmaceutical Contract Packaging Market Revenue Share By Region

13.2. North America

13.2.1. North America Pharmaceutical Contract Packaging Market Revenue By Country

13.2.2. Packaging Type

13.2.3. North America Pharmaceutical Contract Packaging Market Revenue By Packaging Type

13.2.4. Packaging Format

13.2.5. North America Pharmaceutical Contract Packaging Market Revenue By Packaging Format

13.2.6. Dosage Form

13.2.7. North America Pharmaceutical Contract Packaging Market Revenue By Dosage Form

13.2.8. End User

13.2.9. North America Pharmaceutical Contract Packaging Market Revenue By End User

13.3. U.S.

13.4. Canada

13.5. Mexico

CHAPTER NO. 14 : EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET – COUNTRY ANALYSIS

14.1. Europe Pharmaceutical Contract Packaging Market Overview By Country Segment

14.1.1. Europe Pharmaceutical Contract Packaging Market Revenue Share By Region

14.2. Europe

14.2.1. Europe Pharmaceutical Contract Packaging Market Revenue By Country

14.2.2. Packaging Type

14.2.3. Europe Pharmaceutical Contract Packaging Market Revenue By Packaging Type

14.2.4. Packaging Format

14.2.5. Europe Pharmaceutical Contract Packaging Market Revenue By Packaging Format

14.2.6. Dosage Form

14.2.7. Europe Pharmaceutical Contract Packaging Market Revenue By Dosage Form

14.2.8. End User

14.2.9. Europe Pharmaceutical Contract Packaging Market Revenue By End User

14.3. UK

14.4. France

14.5. Germany

14.6. Italy

14.7. Spain

14.8. Russia

14.9. Rest of Europe

CHAPTER NO. 15 : ASIA PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET – COUNTRY ANALYSIS

15.1. Asia Pacific Pharmaceutical Contract Packaging Market Overview By Country Segment

15.1.1. Asia Pacific Pharmaceutical Contract Packaging Market Revenue Share By Region

15.2. Asia Pacific

15.2.1. Asia Pacific Pharmaceutical Contract Packaging Market Revenue By Country

15.2.2. Packaging Type

15.2.3. Asia Pacific Pharmaceutical Contract Packaging Market Revenue By Packaging Type

15.2.4. Packaging Format

15.2.5. Asia Pacific Pharmaceutical Contract Packaging Market Revenue By Packaging Format

15.2.6. Dosage Form

15.2.7. Asia Pacific Pharmaceutical Contract Packaging Market Revenue By Dosage Form

15.2.8. End User

15.2.9. Asia Pacific Pharmaceutical Contract Packaging Market Revenue By End User

15.3. China

15.4. Japan

15.5. South Korea

15.6. India

15.7. Australia

15.8. Southeast Asia

15.9. Rest of Asia Pacific

CHAPTER NO. 16 : LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET – COUNTRY ANALYSIS

16.1. Latin America Pharmaceutical Contract Packaging Market Overview By Country Segment

16.1.1. Latin America Pharmaceutical Contract Packaging Market Revenue Share By Region

16.2. Latin America

16.2.1. Latin America Pharmaceutical Contract Packaging Market Revenue By Country

16.2.2. Packaging Type

16.2.3. Latin America Pharmaceutical Contract Packaging Market Revenue By Packaging Type

16.2.4. Packaging Format

16.2.5. Latin America Pharmaceutical Contract Packaging Market Revenue By Packaging Format

16.2.6. Dosage Form

16.2.7. Latin America Pharmaceutical Contract Packaging Market Revenue By Dosage Form

16.2.8. Form

16.2.9. Latin America Pharmaceutical Contract Packaging Market Revenue By End User

16.3. Brazil

16.4. Argentina

16.5. Rest of Latin America

CHAPTER NO. 17 : MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET – COUNTRY ANALYSIS

17.1. Middle East Pharmaceutical Contract Packaging Market Overview By Country Segment

17.1.1. Middle East Pharmaceutical Contract Packaging Market Revenue Share By Region

17.2. Middle East

17.2.1. Middle East Pharmaceutical Contract Packaging Market Revenue By Country

17.2.2. Packaging Type

17.2.3. Middle East Pharmaceutical Contract Packaging Market Revenue By Packaging Type

17.2.4. Packaging Format

17.2.5. Middle East Pharmaceutical Contract Packaging Market Revenue By Packaging Format

17.2.6. Dosage Form

17.2.7. Middle East Pharmaceutical Contract Packaging Market Revenue By Dosage Form

17.2.8. End User

17.2.9. Middle East Pharmaceutical Contract Packaging Market Revenue By End User

17.3. GCC Countries

17.4. Israel

17.5. Turkey

17.6. Rest of Middle East

CHAPTER NO. 18 : AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET – COUNTRY ANALYSIS

18.1. Africa Pharmaceutical Contract Packaging Market Overview By Country Segment

18.1.1. Africa Pharmaceutical Contract Packaging Market Revenue Share By Region

18.2. Africa

18.2.1. Africa Pharmaceutical Contract Packaging Market Revenue By Country

18.2.2. Packaging Type

18.2.3. Africa Pharmaceutical Contract Packaging Market Revenue By Packaging Type

18.2.4. Packaging Format

18.2.5. Africa Pharmaceutical Contract Packaging Market Revenue By Packaging Format

18.2.6. Dosage Form

18.2.7. Africa Pharmaceutical Contract Packaging Market Revenue By Dosage Form

18.2.8. En User

18.2.9. Africa Pharmaceutical Contract Packaging Market Revenue By End User

18.3. South Africa

18.4. Egypt

18.5. Rest of Africa

CHAPTER NO. 19 : COMPANY PROFILES

19.1. Catalent Pharma Solutions

19.1.1. Company Overview

19.1.2. Service Type Portfolio

19.1.3. Financial Overview

19.1.4. Recent Developments

19.1.5. Growth Strategy

19.1.6. SWOT Analysis

19.2. Sharp Packaging Services

19.3. PCI Pharma Services

19.4. Thermo Fisher Scientific

19.5. Amcor

19.6. North East Pharma Pack

19.7. Aptar Group

19.8. West Pharmaceutical Services

19.9. Berry Global

19.10. Other Key Players

Request A Free Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

Frequently Asked Questions:

What is the current market size for Global Pharmaceutical Contract Packaging Market, and what is its projected size in 2032?

The market was valued at USD 32,946.20 million in 2024. It is projected to reach USD 52,165.40 million by 2032. Growth reflects rising outsourcing and complex packaging needs. Expansion spans branded, generic, and biologic drugs.

At what Compound Annual Growth Rate is the Global Pharmaceutical Contract Packaging Market projected to grow between 2025 and 2032?

The market is expected to grow at a CAGR of 5.92%. Growth remains stable across major regions. Demand strength comes from compliance and scale needs. Long-term contracts support predictable expansion.

Which Global Pharmaceutical Contract Packaging Market segment held the largest share in 2024?

Primary packaging held the largest share in 2024. Direct drug contact drives strict quality demand. High volumes of solid oral and injectables support this segment. Regulatory focus reinforces its dominance.

What are the primary factors fueling the growth of the Global Pharmaceutical Contract Packaging Market?

Key factors include outsourcing trends, regulatory complexity, and biologics growth. Companies seek cost control and faster launches. Specialized expertise drives partner selection. Compliance needs remain a core driver.

Who are the leading companies in the Global Pharmaceutical Contract Packaging Market?

Major players include Catalent Pharma Solutions, PCI Pharma Services, and Sharp Packaging Services. Global firms offer broad service portfolios. Regional players compete through flexibility. Compliance strength defines leadership.

Which region commanded the largest share of the Global Pharmaceutical Contract Packaging Market in 2024?

Asia Pacific held the largest share in 2024. High generic production supports volume demand. Cost advantages attract outsourcing. Export-focused manufacturing strengthens regional dominance.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

Gastric Motility Disorder Drugs Market

Gastric Motility Disorder Drugs Market size was valued at USD 57,750 Million in 2024 and is anticipated to reach USD 87,957.59 Million by 2032, at a CAGR of 5.4% during the forecast period.

Clostridium Difficile Infection (CDI) Treatment Market

Clostridium Difficile Infection (CDI) Treatment market size was valued at USD 1,230 million in 2024 and is anticipated to reach USD 1,944.9 million by 2032, expanding at a CAGR of 5.9% during the forecast period.

Glioblastoma Multiforme Market

The Glioblastoma Multiforme Market shows steady growth driven by unmet medical needs. The market stands at USD 2,770 million in 2024. It is projected to reach USD 5,518.4 million by 2032, growing at a CAGR of 9% during the forecast period.

Tracheitis Treatment Market

Tracheitis Treatment Market size was valued USD 5,736 million in 2024 and is anticipated to reach USD 7,552.67 million by 2032, at a CAGR of 3.5% during the forecast period.

Tamoxifen Market

Tamoxifen Market size was valued at USD 659 Million in 2024 and is anticipated to reach USD 713.06 Million by 2032, at a CAGR of 1% during the forecast period.

Sphingosine-1-Receptor Modulators Drugs Market

Sphingosine-1-Receptor Modulators Drugs Market size was valued at USD 5,650 million in 2024 and is anticipated to reach USD 11,011.52 million by 2032, growing at a CAGR of 8.7% during the forecast period.

Naloxone Market

The global naloxone market was valued at USD 1,020.32 million in 2024 and is projected to reach USD 2,334.48 million by 2032, reflecting a compound annual growth rate (CAGR) of 10.9% over the forecast period.

Neuromyelitis Optica Therapy Market

Neuromyelitis Optica Therapy Market size was valued USD 549 million in 2024 and is anticipated to reach USD 1291.75 million by 2032, at a CAGR of 11.3% during the forecast period.

North America Iron Supplements Market

North America Iron Supplements Market size was valued USD 912 million in 2024 and is anticipated to reach USD 1482.17 million by 2032, at a CAGR of 6.26% during the forecast period.

Neuralgia Treatment Market

Neuralgia Treatment Market size was valued USD 2328 million in 2024 and is anticipated to reach USD 3852.5 million by 2032, at a CAGR of 6.5% during the forecast period.

Neurology Contract Research Organization Market

Neurology Contract Research Organization Market size was valued USD 8489 million in 2024 and is anticipated to reach USD 14048.52 million by 2032, at a CAGR of 6.5% during the forecast period.

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market size was valued USD 2341 million in 2024 and is anticipated to reach USD 4397.91 million by 2032, at a CAGR of 8.2% during the forecast period.

Licence Option

Single User

$4999

Multi User

$6999

Enterprise

$12999

Report delivery within 24 to 48 hours

What people say?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

Request Sample